Cargando…
Fecal calprotectin in daily practice for patients with inflammatory bowel disease: where do we stand in Korea?
Autor principal: | Cha, Jae Myung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Internal Medicine
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325448/ https://www.ncbi.nlm.nih.gov/pubmed/30612419 http://dx.doi.org/10.3904/kjim.2018.401 |
Ejemplares similares
-
Fecal calprotectin in inflammatory bowel disease
por: Walsham, Natalie E, et al.
Publicado: (2016) -
The Role of Carrageenan in Inflammatory Bowel Diseases and Allergic Reactions: Where Do We Stand?
por: Borsani, Barbara, et al.
Publicado: (2021) -
Optimising inflammatory bowel disease surveillance and dysplasia management—Where do we stand?
por: Al Bakir, Ibrahim, et al.
Publicado: (2022) -
The Role of Fecal Calprotectin in Investigating Inflammatory Bowel Diseases
por: Erbayrak, Mustafa, et al.
Publicado: (2009) -
Fecal Calprotectin for the Diagnosis and Management of Inflammatory Bowel Diseases
por: Kapel, Nathalie, et al.
Publicado: (2023)